Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 May;64(5):2433-6.
doi: 10.1128/JVI.64.5.2433-2436.1990.

Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity

Affiliations

Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity

H G Kräusslich et al. J Virol. 1990 May.

Abstract

The poliovirus polyprotein is cotranslationally linked to myristic acid at its amino-terminal glycine residue. We investigated the role of myristoylation in the viral replication cycle by site-directed mutagenesis of this glycine codon. Synthetic full-length RNA transcripts carrying a Gly-to-Ala mutation (G4002A) gave no infectious virus on transfection into permissive cells (HeLa). However, mutant viral RNA was replicated in the transfected cells, albeit at a reduced level. The virus-specific polypeptide P1, the precursor for the capsid proteins, was found in HeLa cells transfected with wild-type or mutant RNA, but only the wild-type P1 was myristoylated; the G4002A mutant P1 was not myristoylated. We also introduced the G4002A mutation into an in vitro transcription-translation vector encoding poliovirus P1 precursor. Processing of the mutant precursor by poliovirus-infected cell lysate (providing 3Cpro and 3CDpro activities) was severely inhibited, whereas the normally inefficient cleavage by purified 3Cpro was not affected. These results suggest that the myristic acid moiety of the P1 precursor may be required for efficient processing by 3CDpro.

PubMed Disclaimer

References

    1. J Gen Virol. 1988 Jul;69 ( Pt 7):1627-36 - PubMed
    1. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7827-31 - PubMed
    1. Annu Rev Biochem. 1988;57:69-99 - PubMed
    1. Annu Rev Biochem. 1988;57:701-54 - PubMed
    1. J Virol. 1988 Dec;62(12):4586-93 - PubMed

Publication types

LinkOut - more resources